ÂÜÀòÂÒÂ×

Dana Stone is a seasoned professional with extensive experience in business analysis, clinical documentation operations, and records management within the pharmaceutical industry. Currently serving as a Senior Business Analyst for eTMF at Haleon since July 2022, Dana previously held managerial roles at GSK, Otsuka Pharmaceutical Companies, Pfizer-Nestlé, Bristol-Myers Squibb, and TEVA/Cephalon. Key accomplishments include implementing enterprise records management systems, leading the transition of Wyeth Nutrition from Pfizer to Nestlé, and developing eCTD capabilities to support clinical trial processes. Dana's educational background includes a Ph.D. in Physiology and a Master of Science in Computer Science from The Ohio State University, along with a Bachelor's degree in Biomedical Information Processing from Rochester Institute of Technology.